TP53 and breast carcinoma: Our data reveal that the transcription coregulator RIP140 inhibits the glycolysis-dependent proliferation of breast cancer cells by impeding glycolysis through the blockade of GLUT3 expression via a mechanism involving a p53-mediated inhibition of HIF activation.